What is allergic conjunctivitis and how is it different from pink eye?

Allergic conjunctivitis is eye inflammation from allergies that causes intense itching, tearing, and redness; it is not contagious. “Pink eye” is a broad term that also includes viral and bacterial infections, which usually cause less itching and may have discharge or spread between people.

Is allergic conjunctivitis serious?

Most cases are mild and self‑limited, but severe forms can affect the cornea and threaten vision if untreated. Intense pain, light sensitivity, or vision changes require urgent eye care to rule out a corneal ulcer or uveitis, which need different treatment.

How long does allergic conjunctivitis last?

Symptoms can last hours to weeks depending on exposure. Seasonal flares may persist throughout a pollen season, while perennial disease can be year‑round with good and bad days. Starting preventive drops before your allergy season often shortens and softens flares.

Can allergic conjunctivitis go away on its own?

Mild episodes often improve once the allergen is avoided, but symptoms commonly recur with re‑exposure. Using cold compresses, artificial tears, and an antihistamine/mast‑cell stabilizer drop speeds relief and helps prevent relapses during the season.

What helps allergic conjunctivitis fast at home?

Cold compresses and lubricating eye drops can give quick relief, and dual‑action allergy eye drops work within minutes. Avoid rubbing your eyes and remove contact lenses. If symptoms persist beyond a few days or vision is affected, seek professional care.

Are allergy eye drops safe to use every day?

Yes, modern dual‑action antihistamine/mast‑cell stabilizer drops are designed for daily use during allergy seasons. Avoid chronic use of “redness relief” vasoconstrictor drops because they can cause rebound redness. Follow label directions and ask an eye care professional if unsure.

Can children get allergic conjunctivitis?

Yes, children commonly have seasonal eye allergies; some develop vernal keratoconjunctivitis, which can be severe. Pediatric cases respond to the same allergy drops but need close monitoring, and any light sensitivity or eye pain should be evaluated urgently.

Will wearing contact lenses make allergic conjunctivitis worse?

Yes, contact lenses can trap allergens and worsen symptoms and may cause giant papillary conjunctivitis. Stop wearing lenses during flares and discuss daily disposable lenses and better hygiene to reduce recurrences once the eyes are quiet.

Do I need allergy shots for allergic conjunctivitis?

Not usually, but allergen immunotherapy can help people with seasonal eye allergies and allergic rhinitis that recur each year. An allergist can test for specific triggers and tailor therapy, which may reduce both nose and eye symptoms over time.

Can allergic conjunctivitis cause vision loss if not treated?

It rarely affects vision in its mild forms, but severe variants (vernal or atopic keratoconjunctivitis) can scar the cornea and impair vision. Prompt treatment of flares and careful use of steroid or steroid‑sparing medicines lower this risk.

What is allergic conjunctivitis? | Symptoms, causes & treatment

Name: Allergic conjunctivitis
Creator: Aleksey Sologub
Published: 2023-11-13

Overview

By Aleksey Sologub, Editor-in-Chief

Allergic conjunctivitis is inflammation of the bulbar and palpebral conjunctiva caused by an IgE‑mediated hypersensitivity to environmental allergens (eg, pollens, animal dander, dust mites) or, in some forms, chronic T‑cell–mediated inflammation. It typically causes intense itching, tearing, redness, and chemosis (conjunctival edema). Diagnosis is clinical based on history and slit‑lamp examination; laboratory testing is rarely needed. Treatment centers on allergen avoidance, cold compresses, lubricants, and topical dual‑action antihistamine/mast‑cell stabilizer drops; short courses of topical corticosteroids are reserved for severe disease or corneal involvement.

Key Points

Itching is the hallmark symptom of allergic conjunctivitis; pain and photophobia suggest alternate or complicated diagnoses.
First‑line therapy for most patients is a topical dual‑action antihistamine/mast‑cell stabilizer (eg, olopatadine, ketotifen), plus allergen avoidance and cold compresses.
Seasonal (SAC) and perennial (PAC) forms are common and usually mild; vernal (VKC) and atopic keratoconjunctivitis (AKC) are sight‑threatening variants requiring specialist care.
Avoid contact lenses during active inflammation; contact lens–related giant papillary conjunctivitis (GPC) improves with discontinuation and hygiene changes.
Topical corticosteroids are effective for severe flares but require intraocular pressure (IOP) monitoring due to risks of glaucoma, cataract, and infection reactivation.
Consider allergen immunotherapy for patients with concomitant allergic rhinitis whose ocular symptoms recur each season.

Anatomy and Physiology

The conjunctiva is a thin, vascularized mucous membrane lining the posterior eyelids (palpebral conjunctiva) and reflecting onto the globe (bulbar conjunctiva). Goblet cells produce mucins critical to tear film stability. The tarsal conjunctiva harbors immune effector cells, including mast cells and eosinophils. The superior tarsal plate forms prominent papillae in allergic disease; limbal tissue can form Horner‑Trantas dots (eosinophil aggregates) in VKC.

Etiology

Environmental aeroallergens: pollens (trees, grasses, weeds), house dust mites, animal dander, molds.
Mechanical/foreign body–related: contact lenses (especially reusable soft lenses), exposed sutures, ocular prostheses (GPC).
Atopic diathesis: association with atopic dermatitis, asthma, and allergic rhinitis (notably in AKC and VKC).
Occupational/indoor triggers: feathers, chemicals, occupational dusts.
Medication‑related conjunctival hypersensitivity or medicamentosa (eg, preservatives like benzalkonium chloride).

Pathophysiology

Immediate (Type I) hypersensitivity: Allergen cross‑links IgE on conjunctival mast cells, releasing histamine and other mediators, causing vasodilation, itching via H1 receptors, and chemosis (SAC/PAC).
Late‑phase and chronic inflammation: Recruitment of eosinophils, Th2 lymphocytes, and cytokines sustains inflammation, leading to papillary hypertrophy, mucus hypersecretion, and, in severe forms (VKC/AKC), corneal epithelial toxicity and shield ulcers.
Mechanical microtrauma: Contact lens edge and deposits stimulate papillary hypertrophy (GPC).

Epidemiology

Allergic conjunctivitis is common in the United States and frequently coexists with allergic rhinitis. Prevalence estimates vary by method and region; population surveys suggest that a substantial proportion of individuals with seasonal allergies report ocular itching and redness each year. VKC is uncommon in temperate climates and primarily affects boys in late childhood; AKC typically presents in young adults with chronic atopic dermatitis [1][2].

Classification

Seasonal allergic conjunctivitis (SAC): Intermittent, pollen‑driven flares (spring/summer/fall).
Perennial allergic conjunctivitis (PAC): Year‑round, often due to dust mites, animal dander, molds; milder but chronic.
Vernal keratoconjunctivitis (VKC): Chronic, seasonal exacerbations; large superior tarsal papillae, limbal inflammation, risk of shield ulcers; pediatric‑predominant.
Atopic keratoconjunctivitis (AKC): Chronic, often bilateral, associated with atopic dermatitis; can cause cicatrization, keratopathy, and vision loss.
Giant papillary conjunctivitis (GPC), also called contact lens–induced papillary conjunctivitis (CLPC): Papillary hypertrophy of the superior tarsal conjunctiva from contact lenses, exposed sutures, or prostheses.

Symptoms and Signs

Seasonal and Perennial Allergic Conjunctivitis (SAC/PAC)

Symptoms: Intense itching, tearing (epiphora), burning, mild photophobia, watery or stringy mucus discharge, eyelid swelling. Often with allergic rhinitis (sneezing, nasal congestion).
Signs: Conjunctival hyperemia, chemosis, mild eyelid edema, papillary reaction (small papillae) on tarsal conjunctiva; clear cornea.

Vernal Keratoconjunctivitis (VKC)

Symptoms: Severe itching, photophobia, foreign‑body sensation, ropy mucus discharge; seasonal worsening.
Signs: Giant “cobblestone” papillae on superior tarsal conjunctiva; limbal thickening with Horner‑Trantas dots; punctate keratopathy; risk of superior corneal shield ulcers and plaques.

Atopic Keratoconjunctivitis (AKC)

Symptoms: Chronic itching, burning, photophobia, mucus discharge; often perennial with flares.
Signs: Lid skin eczema with fissuring; tarsal papillae; conjunctival scarring; symblepharon in severe cases; punctate epithelial erosions; keratoconus association reported [2].

Giant Papillary Conjunctivitis (GPC/CLPC)

Symptoms: Itching worse after lens removal, mucus discharge, decreased lens tolerance, lens awareness.
Signs: Enlarged superior tarsal papillae, mucus strands, lens deposits; cornea usually clear unless coexisting keratitis.

Complications

Corneal involvement: Punctate epithelial erosions, shield ulcers (VKC), microbial keratitis from eye rubbing or lens wear.
Vision impairment: From corneal scarring, irregular astigmatism, or keratoconus progression [2].
Medication adverse effects: Steroid‑induced ocular hypertension/glaucoma, posterior subcapsular cataract, herpetic keratitis reactivation; rebound hyperemia with chronic vasoconstrictor use.
Contact lens complications: Intolerance, increased risk of infectious keratitis.

Diagnosis

Clinical evaluation

History: Onset relative to allergen exposure or seasons, severity of itching, presence of rhinitis/asthma/atopic dermatitis, contact lens type and hygiene, prior response to drops, use of vasoconstrictors or preserved medications.
Examination: Visual acuity; external and slit‑lamp exam for tarsal papillae, hyperemia, chemosis, limbal changes, Trantas dots; fluorescein staining to assess corneal epithelium; eyelid skin for dermatitis.
Pain, marked photophobia, or reduced vision warrants careful corneal evaluation to exclude keratitis or uveitis.

Imaging and laboratory testing

Not routinely required.
Conjunctival cytology may show eosinophils; helpful in atypical or refractory cases.
Allergen evaluation (skin‑prick or serum‑specific IgE) guided by history when considering allergen immunotherapy or when diagnosis is uncertain; coordinate with allergy specialists [3][4].

Differential diagnosis

Entity	Distinguishing features
Viral conjunctivitis (adenoviral)	Follicles, preauricular lymphadenopathy, watery discharge, recent URI; highly contagious
Bacterial conjunctivitis	Mucopurulent discharge, eyelids stuck in morning, minimal itching; no seasonal pattern
Dry eye disease	Burning, fluctuating vision, worsens late day, positive staining of interpalpebral cornea; minimal itching
Blepharitis/meibomian gland dysfunction	Lid margin crusting, chalazia, morning irritation; improves with lid hygiene
Contact dermatitis of eyelids	Lid erythema/edema, pruritus, scaling; periocular exposure history
Drug‑induced conjunctivitis (medicamentosa)	Chronic redness on preserved drops (eg, glaucoma meds), inferior conjunctival changes; improves with discontinuation
Keratitis (bacterial, herpetic, Acanthamoeba)	Pain, photophobia, focal corneal infiltrate/ulcer, anterior chamber reaction; urgent evaluation needed
Anterior uveitis (iritis)	Photophobia, ciliary flush, cells/flare in anterior chamber; small pupil
Scleritis/episcleritis	Focal/diffuse deep redness; scleritis has severe pain and tenderness
Acute angle‑closure glaucoma	Severe pain, halos, mid‑dilated pupil, corneal edema, high IOP; emergency
Subconjunctival hemorrhage	Painless, sharply demarcated red patch; no discharge or itching

Treatment

Medical management

Nonpharmacologic

Allergen avoidance (keep windows closed during pollen peaks, shower after outdoor exposure, use high‑efficiency particulate air [HEPA] filtration).
Cold compresses 10–15 minutes as needed; preservative‑free artificial tears 4–8 times/day to dilute allergens and mediators.
Suspend contact lens wear during active inflammation; consider daily disposable lenses once quiet.

Topical antihistamine/mast‑cell stabilizer combinations (first‑line for SAC/PAC)

Olopatadine 0.1% 1 drop bid or 0.2% qd.
Ketotifen 0.025% (OTC) 1 drop bid.
Alcaftadine 0.25% 1 drop qd.
Epinastine 0.05% 1 drop bid.
Bepotastine 1.5% 1 drop bid.
Azelastine 0.05% 1 drop bid.
Onset within minutes; continue through the allergen season for prevention [1][5].

Mast‑cell stabilizers (for prophylaxis; slower onset over days–weeks)

Cromolyn sodium 4% 1 drop qid.
Nedocromil 2% 1 drop bid.
Lodoxamide 0.1% 1 drop qid.

Adjuncts

Oral second‑generation antihistamines (cetirizine 10 mg PO qd, loratadine 10 mg PO qd, fexofenadine 180 mg PO qd) for patients with significant rhinitis; may worsen ocular dryness.
Topical NSAIDs (eg, ketorolac 0.5% 1 drop qid) have limited additional benefit and may sting; not first‑line [1].
Topical vasoconstrictor/antihistamine OTC combinations (eg, naphazoline/pheniramine) can reduce redness/itching short‑term; limit to brief use due to rebound hyperemia and risk of angle‑closure in susceptible eyes; avoid in narrow‑angle glaucoma [DailyMed/FDA label].

Topical corticosteroids (for severe flares, VKC/AKC with corneal involvement)

Loteprednol etabonate 0.2–0.5% 1 drop qid (then taper).
Fluorometholone 0.1% 1 drop qid (then taper).
Use the lowest effective dose for the shortest duration; monitor IOP and lens status; exclude active herpetic keratitis [1][6].

Calcineurin inhibitors (steroid‑sparing; off‑label in the US for allergic indications)

Cyclosporine ophthalmic emulsion 0.05% 1 drop bid for chronic VKC/AKC refractory to standard therapy (FDA‑approved for dry eye; off‑label here) [2].
Tacrolimus 0.03% dermatologic ointment applied thinly to eyelid skin bid for lid eczema in AKC; avoid direct instillation unless compounded; off‑label [2].

Allergen immunotherapy

Subcutaneous or sublingual allergen immunotherapy can reduce ocular symptoms in SAC/PAC with concomitant allergic rhinitis when targeted to confirmed allergens; coordinated with an allergist [3][4].

GPC‑specific measures

Discontinue contact lens wear for 2–4 weeks; switch to daily disposables or rigid gas‑permeable lenses; improve lens hygiene and replace frequently.
Treat inflammation with dual‑action drops; consider a short steroid course if severe.

Procedural and surgical management

VKC shield ulcers with non‑adherent plaques: Debridement of plaque and placement of a bandage soft contact lens; topical antibiotic prophylaxis during epithelial healing.
Recalcitrant VKC/AKC: Consider supratarsal corticosteroid injection in select cases under ophthalmologist supervision; reserved due to risk profile [2].
Mechanical sources of GPC (exposed sutures): Remove or revise the irritant.

Special populations

Pediatric: VKC occurs in school‑age boys; prioritize dual‑action drops, allergen avoidance, and careful steroid use with IOP monitoring. Educate to avoid eye rubbing to reduce keratopathy risk.
Pregnancy/lactation: Prefer nonpharmacologic measures first. Topical dual‑action agents have low systemic absorption; use if benefits outweigh risks. Avoid prolonged use of topical vasoconstrictors. Coordinate with obstetric providers; choose oral agents with established safety if needed (eg, loratadine, cetirizine).
Immunocompromised: Use steroids cautiously; rule out herpetic keratitis before initiating. Monitor closely for infection.
Older adults: Oral antihistamines may exacerbate dry eye and can cause sedation; avoid first‑generation agents. Avoid vasoconstrictors in narrow‑angle glaucoma.

Prognosis

SAC/PAC: Excellent with avoidance and topical therapy; symptoms typically remit when exposure ends.
GPC: Improves with lens holiday and hygiene modifications; recurrence possible if risk factors persist.
VKC: Often improves after adolescence; corneal complications can threaten vision without aggressive control.
AKC: Chronic relapsing course into adulthood with risk of cicatrization and keratopathy; requires long‑term management and monitoring [1][2].

Prevention and Patient Counseling

Start dual‑action drops 1–2 weeks before predictable pollen seasons (SAC).
Minimize exposure: check pollen counts, keep windows closed, use air conditioning with high‑quality filters, shower after outdoor activities, and avoid rubbing eyes.
Use preservative‑free artificial tears regularly during high‑exposure days.
Avoid chronic use (>2 weeks) of OTC “redness relief” vasoconstrictor drops.
Suspend contact lens wear during active symptoms; consider daily disposables thereafter.
Adhere to follow‑up when using topical steroids for IOP checks.

When to Seek Immediate Care

Sudden decrease in vision in either eye.
Moderate to severe eye pain or significant light sensitivity.
A white spot on the cornea or suspected corneal ulcer.
Copious pus‑like discharge or eyelids matted shut throughout the day.
Symptoms in a contact lens wearer that do not improve promptly after removing lenses.
Use of steroid eye drops without medical supervision.

References

American Academy of Ophthalmology Cornea/External Disease Panel. Conjunctivitis Preferred Practice Pattern. San Francisco, CA: AAO; 2023. https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2023
EyeWiki (AAO). Allergic Conjunctivitis. https://eyewiki.aao.org/Allergic_Conjunctivitis
MedlinePlus. Allergic Conjunctivitis. National Library of Medicine. https://medlineplus.gov/ency/article/001011.htm
Wallace DV, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1-S84. doi:10.1016/j.jaci.2008.06.003
Calderon MA, et al. Topical antihistamines and mast cell stabilisers for seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev. 2015;(6):CD009566. doi:10.1002/14651858.CD009566.pub2
DailyMed. Loteprednol Etabonate Ophthalmic Suspension. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov

Closing disclaimer: This article is for informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified eye care professional about your specific condition. If you have sudden vision loss, severe eye pain, or an eye injury, seek emergency care immediately.